Results 221 to 230 of about 13,547 (264)

Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan. [PDF]

J Gynecol Oncol
Choi CH, Lee YY, Lai YL, Chang K, Kim HS, Chen J, Chen YL.   +6 more
europepmc   +1 more source

The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial. [PDF]

J Gynecol Oncol
Alnemr AA, Harb OA, Atia H.
europepmc   +1 more source

Transforming growth factor β signaling in uterine development and function [PDF]

, 2014

core   +1 more source

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia. [PDF]

J Gynecol Oncol
Lv X, Guo L, Wang C.
europepmc   +1 more source

End-to-end deep learning method for predicting hormonal treatment response in women with atypical endometrial hyperplasia or endometrial cancer. [PDF]

J Med Imaging (Bellingham)
Kahaki S, Hagemann IS, Cha KH, Trindade C, Petrick N, Kostelecky N, Borden LE, Atwi D, Fung KM, Chen W.   +9 more
europepmc   +1 more source

Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma. [PDF]

J Gynecol Oncol
Li X, Wang Y, Wang J, Zhou J, Wang J.
europepmc   +1 more source

Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women [PDF]

, 2014
Rostyslav V Bubnov, Sergiy M Bashynskyi, Vadym M Goncharenko, Vasyl A Beniuk, Yaroslav M Vyniarskyi   +4 more
core   +1 more source

CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival [PDF]

, 2016

core   +1 more source

[Megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early-stage endometrial adenocarcinoma: a prospective study]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Y, Lai T, Chu D, Bai J, Yan S, Qin H, Guo R.   +6 more
europepmc   +1 more source

Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study [PDF]

, 2013

core   +1 more source